fda import alert 66-80 glp-1 green list Compounded Semaglutide & Tirzepatide 2025: Safe Use Guide Did you know that being

If you reach a plateau or your goals change, we adjust your doseup, down, or steadyto keep your treatment working for you

Fit, energized, in their prime

The Cycling Reality A fascinating five-year analysis by Optum tracked prescription patterns for 135,089 GLP-1 users, uncovering a clear seasonal rhythm to the medication's popularity

This aligns with findings from SURPASS-CVOT, which showed no meaningful additive effect on MACE compared to an older GLP-1 receptor agonist, and with findings of a potential greater protection in heart failure that could be compatible with more pronounced weight loss mediated by GIP 16,22

These effects are typically temporary and subside shortly after the infusion